October 19, 2011 — Hologic Inc. announced the six-year follow-up results from the MammoSite Registry Study continue to show promising results for breast cancer patients. The results were presented at the American Society of Radiation Oncology (ASTRO) meeting in Miami, Florida, Oct. 3. The company featured its next-generation MammoSite ML (multi-lumen) radiation therapy.

The American Society of Breast Surgeons (ASBS) MammoSite Registry of more than 1,400 patients shows "excellent/good" cosmetic results in 90.4 percent of the cases. Hologic's MammoSite system is the only breast brachytherapy balloon system with six years of follow-up registry data.

According to Peter Beitsch, M.D., FACS, a surgeon at the Dallas Breast Center in Texas and lead author of the study, "The ASBS MammoSite Registry has contributed to the acceptance of accelerated partial breast irradiation (APBI) across this country and the world by the reassuring long-term data on local control, lack of risk of regional recurrence in the era of the sentinel node biopsy, and the comparable long-term survival after whole breast irradiation."

By employing MammoSite therapy, the radiation oncologist can deliver targeted radiation therapy directly to the area where cancer is most likely to recur, allowing a full course of radiation to be delivered in just five days. Additionally, targeted therapy of the breast limits radiation exposure to normal, healthy tissue. This targeting helps minimize side effects such as skin discoloration and scarring, burning, fatigue, and damage to surrounding organs. It also allows treatment of patients otherwise not appropriate candidates for traditional brachytherapy.

For more information: www.hologic.com

Related Content

News | Magnetic Resonance Imaging (MRI)

December 1, 2021 — In the first MRI-based study to investigate prenatal alcohol exposure, researchers found significant ...

Time December 01, 2021
arrow
News | Coronavirus (COVID-19)

November 30, 2021 — COVID-19 of mild to moderate severity in pregnant women appears to have no effect on the brain of ...

Time November 30, 2021
arrow
News | Computed Tomography (CT)

November 30, 2021 — A three-year study of more than 1,000 patients found that the risk of delayed intracranial ...

Time November 30, 2021
arrow
News | Coronavirus (COVID-19)

November 29, 2021 — The largest multi-institutional international study to date on brain complications of COVID-19 has ...

Time November 29, 2021
arrow
News | Coronavirus (COVID-19)

November 24, 2021 — Significant decreases in CT imaging for cancer persisted even after the peak of the COVID-19 ...

Time November 24, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

November 23, 2021 — Researchers at Yale University analyzing specialized MRI exams found significant changes in the ...

Time November 23, 2021
arrow
News | Interventional Radiology

November 23, 2021 — A minimally invasive ablation procedure offers long-term relief for patients who experience chronic ...

Time November 23, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

November 22, 2021 — Adolescents and young adults with post-concussive symptoms who suffered three to five concussions ...

Time November 22, 2021
arrow
News | Artificial Intelligence

November 18, 2021 — VIDA Diagnostics Inc. (VIDA) is further removing friction in respiratory clinical trials with the ...

Time November 18, 2021
arrow
News | Radiation Therapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Subscribe Now